Britta Otte

Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.

C. Fitzner, F. Eitner, T. Rauen, 2017, Journal of the American Society of Nephrology : JASN.

After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy.

C. Wanner, T. Benzing, F. Artunc, 2020, Kidney international.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

G. Francis, Qian Wang, D. Gaudet, 2021, The Lancet.

CaRe high - Cascade screening and registry for high cholesterol in Germany.

W. März, C. Wanner, U. Laufs, 2017, Atherosclerosis. Supplements.

Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry.

H. Schunkert, W. März, U. Laufs, 2018, Atherosclerosis.

Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency.

B. Nordestgaard, E. Steinhagen-Thiessen, H. Petry, 2016, Journal of clinical lipidology.

Prevalence of unknown atrial fibrillation in patients with risk factors.

Paulus Kirchhof, Alexander Samol, Johannes Waltenberger, 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network.

E. Hagström, Pankaj Gupta, Wolfgang Reinhardt, 2023, Atherosclerosis.

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.

C. Fitzner, F. Eitner, T. Rauen, 2015, The New England journal of medicine.

Infection by Candida albicans inhibits apoptosis of human monocytes and monocytic U937 cells

S. Heidenreich, Britta Otte, D. Lang, 1996, Journal of leukocyte biology.

The German CaRe high registry for familial hypercholesterolemia – Sex differences, treatment strategies, and target value attainment

A. Baessler, H. Schunkert, W. März, 2023, Atherosclerosis plus.

Prevalence of unknown atrial fibrillation in patients with risk factors.

P. Kirchhof, E. Ringelstein, H. Pavenstädt, 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

G. Francis, Qian Wang, D. Gaudet, 2021, Lancet.